Navrongo Health Research Centre, Ghana Health Service, Navrongo, Ghana.
Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
JAMA Netw Open. 2022 Apr 1;5(4):e227559. doi: 10.1001/jamanetworkopen.2022.7559.
Carotid atherosclerosis and microalbuminuria are associated with atherosclerotic cardiovascular disease (ASCVD) but are understudied in sub-Saharan Africa.
To evaluate the association of carotid atherosclerosis and microalbuminuria with 10-year ASCVD risk in middle-aged sub-Saharan African individuals.
DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study conducted analyses of baseline data from the African-Wits-INDEPTH (International Network for the Demographic Evaluation of Populations and Their Health in Low- and Middle-Income Countries) genomic study (AWI-Gen). Women and men aged 40 to 60 years without baseline CVD and drawn from Burkina Faso, Ghana, Kenya, and South Africa were included.
Hypotheses for the analyses were formulated after data collection. The main exposures were carotid atherosclerosis, assessed using carotid intima-media thickness (CIMT) using B-mode ultrasonography, and microalbuminuria, measured using spot urine albumin (SUA) and urine albumin-creatinine ratio (uACR). The main outcome was high ASCVD risk, defined as a 2018 Pooled Cohort Equations score of 7.5% or greater. Associations were estimated using adjusted multivariable logistic regression analyses.
A total of 9010 participants with a mean (SD) age of 50 (6) years and 4533 (50.3%) women were included. High CIMT, SUA, and uACR were each associated with older age (eg, mean [SD] age of participants with high vs reference range CIMT: 55 [5] years vs 50 [6] years; P < .001) and high prevalence of both diabetes and hypertension (eg, hypertension among those with high vs reference range SUA: 213 of 1117 [19.1%] vs 356 of 2549 [14.0%]; P < .001). Smokers were likely to have higher vs reference range SUA (210 [18.8%] vs 407 [16.0%]) and uACR (138 of 707 [19.5%] vs 456 of 2797 [16.3%]). Carotid atherosclerosis was common in Burkina Faso (82 of 262 [31.3%]) and Ghana (91 [34.7%]), while microalbuminuria, measured by SUA, was common in Kenya (272 [24.4%]) and South Africa (519 [46.5%]). SUA was associated with higher odds of carotid atherosclerosis (odds ratio [OR], 1.77; 95% CI, 1.04-3.01) compared with uACR (OR, 0.51; 95% CI, 0.27-0.95). Common CIMT, SUA, and uACR were associated with 10-year ASCVD risk, with CIMT having a stronger association with 10-year ASCVD risk in both women (OR, 1.95; 95% CI, 1.78-2.14) and men (OR, 1.73; 95% CI, 1.55-1.93) than SUA (women: OR, 1.29; 95% CI, 1.12-1.43; men: OR, 1.46; 95% CI, 1.26-1.55) and uACR (women: OR, 1.32; 95% CI, 1.10-1.54; men: OR, 1.35; 95% CI, 1.15-1.46).
The presence of microalbuminuria measured by SUA may indicate risk of subclinical carotid atherosclerosis and high 10-year ASCVD risk in middle-aged residents of sub-Saharan Africa. These data should be confirmed in longitudinal studies of cardiovascular events.
颈动脉粥样硬化和微量白蛋白尿与动脉粥样硬化性心血管疾病(ASCVD)相关,但在撒哈拉以南非洲地区研究较少。
评估中年撒哈拉以南非洲个体的颈动脉粥样硬化和微量白蛋白尿与 10 年 ASCVD 风险的关系。
设计、地点和参与者:这项横断面研究对非洲-威特斯-INDEPTH(国际人口评估和人口及其在中低收入国家的健康网络)基因组研究(AWI-Gen)的基线数据进行了分析。包括来自布基纳法索、加纳、肯尼亚和南非的年龄在 40 至 60 岁之间、无基线 CVD 的女性和男性。
数据分析的假设是在数据收集后制定的。主要暴露因素是颈动脉粥样硬化,使用 B 型超声检查评估颈动脉内膜中层厚度(CIMT),微量白蛋白尿使用尿白蛋白(SUA)和尿白蛋白-肌酐比(uACR)进行测量。主要结局是 ASCVD 风险高,定义为 2018 年合并队列方程评分大于等于 7.5%。使用调整后的多变量逻辑回归分析来估计关联。
共纳入 9010 名参与者,平均(SD)年龄为 50(6)岁,其中 4533 名(50.3%)为女性。高 CIMT、SUA 和 uACR 与年龄较大(例如,高 vs 参考范围 CIMT 参与者的平均年龄:55 [5] 岁 vs 50 [6] 岁;P<0.001)和高患病率的糖尿病和高血压(例如,高 vs 参考范围 SUA 的高血压:1117 名中的 213 名[19.1%] vs 2549 名中的 356 名[14.0%];P<0.001)相关。吸烟者的 SUA(210[18.8%] vs 407[16.0%])和 uACR(707[19.5%]中的 138 名 vs 2797[16.3%]中的 456 名)可能更高。在布基纳法索(82/262[31.3%])和加纳(91/347[34.7%]),颈动脉粥样硬化较为常见,而在肯尼亚(272/1108[24.4%])和南非(519/1305[46.5%]),微量白蛋白尿,通过 SUA 测量,更为常见。SUA 与颈动脉粥样硬化的高几率相关(比值比[OR],1.77;95%CI,1.04-3.01),与 uACR(OR,0.51;95%CI,0.27-0.95)相比。常见的 CIMT、SUA 和 uACR 与 10 年 ASCVD 风险相关,CIMT 与女性(OR,1.95;95%CI,1.78-2.14)和男性(OR,1.73;95%CI,1.55-1.93)的 10 年 ASCVD 风险的关联均强于 SUA(女性:OR,1.29;95%CI,1.12-1.43;男性:OR,1.46;95%CI,1.26-1.55)和 uACR(女性:OR,1.32;95%CI,1.10-1.54;男性:OR,1.35;95%CI,1.15-1.46)。
用 SUA 测量的微量白蛋白尿的存在可能表明亚临床颈动脉粥样硬化和中年撒哈拉以南非洲居民的高 10 年 ASCVD 风险。这些数据应在心血管事件的纵向研究中得到证实。